Mark M Zalupski Selected Research

pegfilgrastim (Neulasta)

1/2020

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark M Zalupski Research Topics

Disease

33	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 05/2002
26	Neoplasms (Cancer) 01/2023 - 08/2002
11	Adenocarcinoma 01/2018 - 08/2002
7	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 01/2005
6	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 02/2004
4	Fatigue 10/2022 - 01/2013
4	Neutropenia 10/2022 - 01/2005
4	Disease Progression 12/2018 - 05/2005
3	Cholangiocarcinoma 01/2023 - 08/2015
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023 - 10/2022
3	Carcinoma (Carcinomatosis) 04/2021 - 08/2007
3	Nausea 06/2019 - 01/2013
3	Thrombocytopenia (Thrombopenia) 08/2013 - 01/2005
2	Diarrhea 06/2019 - 02/2004
2	Neoplasm Metastasis (Metastasis) 06/2015 - 08/2007
2	Cholangitis 01/2014 - 08/2013
2	Weight Loss (Weight Reduction) 01/2013 - 02/2006
2	Rectal Neoplasms (Rectal Cancer) 01/2013 - 08/2007
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2011 - 11/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2023
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Vision Disorders (Hemeralopia) 12/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Dysarthria (Spastic Dysarthria) 06/2019
1	Flushing 06/2019
1	Neurologic Manifestations (Neurological Manifestations) 06/2019
1	Rhinorrhea 06/2019
1	Paresthesia (Dysesthesia) 06/2019
1	Exanthema (Rash) 02/2017
1	Vomiting 02/2017
1	Margins of Excision 08/2015
1	Carcinogenesis 06/2015
1	Klatskin Tumor 01/2014

Drug/Important Bio-Agent (IBA)

35	Gemcitabine FDA Link 01/2023 - 05/2002
9	Capecitabine (Xeloda)FDA Link 01/2023 - 02/2004
9	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 05/2002
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 02/2004
6	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2002
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2013
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 02/2008
4	Ifosfamide FDA LinkGeneric 09/2015 - 02/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 02/2004
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2021
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 04/2009
2	folfirinoxIBA 01/2020 - 06/2019
2	Bevacizumab (Avastin)FDA Link 06/2019 - 01/2013
2	PlatinumIBA 12/2018 - 01/2018
2	Drug CombinationsIBA 12/2018 - 02/2004
2	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018 - 07/2010
2	HhAntag691IBA 12/2014 - 01/2013
2	Phosphotransferases (Kinase)IBA 06/2013 - 12/2011
2	CarbohydratesIBA 05/2013 - 01/2013
2	AntigensIBA 05/2013 - 01/2013
2	CreatinineIBA 12/2012 - 06/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 01/2005
2	Imatinib Mesylate (Gleevec)FDA Link 12/2011 - 11/2002
2	EnzymesIBA 02/2008 - 12/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2008 - 12/2005
2	Celecoxib (Celebrex)FDA Link 02/2008 - 12/2005
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2008 - 12/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	ReninIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	AngiotensinsIBA 01/2023
1	devimistatIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	Transaminases (Aminotransferases)IBA 10/2022
1	Death Domain ReceptorsIBA 10/2022
1	NivolumabIBA 10/2022
1	LigandsIBA 10/2022
1	IpilimumabIBA 10/2022
1	pegfilgrastim (Neulasta)FDA Link 01/2020
1	adavosertibIBA 10/2019
1	Topoisomerase I InhibitorsIBA 06/2019
1	Cholinergic Agents (Cholinergics)IBA 06/2019
1	AlbuminsIBA 12/2018
1	PEGPH20IBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2018
1	Thymidylate SynthaseIBA 01/2018
1	binimetinibIBA 02/2017
1	cabozantinibIBA 12/2016
1	Cysteine (L-Cysteine)FDA Link 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Blood Proteins (Serum Proteins)IBA 01/2016
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Caveolin 1IBA 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2014
1	AgarIBA 12/2014

Therapy/Procedure

31	Therapeutics 01/2023 - 05/2002
22	Radiotherapy 01/2020 - 05/2002
17	Drug Therapy (Chemotherapy) 10/2022 - 08/2002
6	Neoadjuvant Therapy 01/2018 - 02/2004
5	Chemoradiotherapy 10/2017 - 05/2002
3	Combination Drug Therapy (Combination Chemotherapy) 12/2009 - 01/2005
1	Adjuvant Chemotherapy 01/2016
1	Pancreaticoduodenectomy 10/2014